Protective agent for nervous system structural cells
    4.
    发明授权
    Protective agent for nervous system structural cells 失效
    神经系统结构细胞的保护剂

    公开(公告)号:US06340693B1

    公开(公告)日:2002-01-22

    申请号:US09180772

    申请日:1999-02-16

    IPC分类号: A61K3144

    CPC分类号: A61K31/5585

    摘要: The present invention provides a protective agent for nervous system structural cells comprising a prostaglandin I derivative, preferably a prostaglandin I2 derivative, particularly beraplost, as an active component. This medicine exhibits excellent effects as a protective agent for nervous system structural cells, and is effective as an excellent agent for preventing or curing cerebrovascular disorder, cerebral nerve cell disorder, ischemic cerebral disorder, dementia, and peripheral nerve disorder due to diabetic or the like.

    摘要翻译: 本发明提供了一种用于神经系统结构细胞的保护剂,其包含前列腺素I衍生物,优选前列腺素I 2衍生物,特别是beraplost作为活性成分。 该药作为神经系统结构细胞的保护剂具有优异的效果,作为预防或治疗由于糖尿病等引起的脑血管障碍,脑神经细胞障碍,缺血性脑病,痴呆和周围神经障碍的优异剂,是有效的 。

    THERAPEUTIC AGENT FOR CHRONIC RENAL FAILURE
    7.
    发明申请
    THERAPEUTIC AGENT FOR CHRONIC RENAL FAILURE 有权
    慢性肾衰竭治疗药物

    公开(公告)号:US20110178103A1

    公开(公告)日:2011-07-21

    申请号:US13055242

    申请日:2009-07-23

    CPC分类号: C07D241/20 A61K31/4965

    摘要: The present invention aims to provide a therapeutic agent for chronic renal failure, comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof. That is, the present invention provides provision of a drug comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof, which drug is useful not only for amelioration of renal function, but also for amelioration of anemia, activation of SOD and excretion of uremic substances.

    摘要翻译: 本发明旨在提供一种用于慢性肾功能衰竭的治疗剂,其包含作为有效成分的由通式(1)表示的化合物或其药学上可接受的盐。 也就是说,本发明提供包含作为有效成分的由通式(1)表示的化合物或其药学上可接受的盐的药物的提供,该药物不仅可用于改善肾功能,还可用于改善贫血 ,激活SOD和排泄尿毒症物质。